TGR5 agonists (Hanmi Pharmaceutical/Chung-Ang/Korea University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameTGR5 agonists (Hanmi Pharmaceutical/Chung-Ang/Korea University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled bile acid receptor 1 agonists
TargetsG-protein coupled bile acid receptor 1
Therapy Area/IndicationsMetabolic DiseasesLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanmi Pharmaceutical Co LtdChung-Ang UniversityKorea University
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesLiver Diseases

Other Information

ATC CodeN/A
Related LinksN/A